<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04876963</url>
  </required_header>
  <id_info>
    <org_study_id>HOLT-ED protocol 1.10</org_study_id>
    <nct_id>NCT04876963</nct_id>
  </id_info>
  <brief_title>HOLT-ED: Holter-monitoring in End-stage Renal Disease</brief_title>
  <official_title>HOLT-ED: Holter-monitoring in End-stage Renal Disease - Does Burden of Arrhythmia Assessed With Systematic Holter Electrocardiogram Monitoring Affect Cardiovascular Outcomes? - A Prospective Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of this prospective cohort study is to assess arrhythmia burden and&#xD;
      glycemic variability in a multicenter cohort of patients with end-stage renal disease using a&#xD;
      sufficient observation period in order to identify arrhythmia burden and type and&#xD;
      characterize associations with patient characteristics and dialysis treatment, glycemic&#xD;
      variability and subsequent risk of adverse outcomes.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: The risk of dying of a cardiovascular disease is 10-20 times increased in&#xD;
      patients dependent on dialysis treatment compared to the general population. 1/3 of these&#xD;
      deaths is caused by arrhythmia and 'sudden cardiac death'.&#xD;
&#xD;
      Purpose: Investigate the prevalence and type of arrhythmia in patients dependent on dialysis&#xD;
      treatment, including the association with patient- and dialysis related factors and&#xD;
      cardiovascular outcomes.&#xD;
&#xD;
      Methods: 7-days Holter-monitoring with Cortrium C3+ holter-monitor in 540 patients dependent&#xD;
      on dialysis treatment in the Capital Region of Denmark. Continous blood glucose monitoring in&#xD;
      a subgroup. 1-year follow-up via national registers.&#xD;
&#xD;
      Endpoints:&#xD;
&#xD;
        -  Prevalence of atrial fibrillation&#xD;
&#xD;
        -  Prevalence of other arrhythmia (tachycardia, bradycardia, AV-block)&#xD;
&#xD;
        -  Follow-up outcomes: sudden cardiac death, cardiovascular disease and cardiovascular&#xD;
           death&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2021</start_date>
  <completion_date type="Anticipated">August 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Sudden cardiac death / lethal arrhythmia</measure>
    <time_frame>1-year follow up</time_frame>
    <description>Risk of sudden cardiac death or lethal arrhythmia within one year</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cardiovascular death</measure>
    <time_frame>1-year follow up</time_frame>
    <description>Risk of cardiovascular death within one year</description>
  </primary_outcome>
  <primary_outcome>
    <measure>All-cause mortality</measure>
    <time_frame>1-year follow up</time_frame>
    <description>Risk of all-cause mortality within one year</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Myocardial infarction or death attributable to myocardial infarction</measure>
    <time_frame>1-year follow up</time_frame>
    <description>Risk of Myocardial infarction or death attributable to myocardial infarction within one year</description>
  </primary_outcome>
  <other_outcome>
    <measure>Clinical hypoglycemia</measure>
    <time_frame>Baseline</time_frame>
    <description>Clinical hypoglycemia in connection with holtermonitoring at baseline</description>
  </other_outcome>
  <other_outcome>
    <measure>De novo cardiac arrhythmia (atrial fibrillation or flutter, advanced second-degree or third degree</measure>
    <time_frame>Baseline</time_frame>
    <description>De novo cardiac arrhythmia (atrial fibrillation or flutter, advanced second-degree or third degree at baseline</description>
  </other_outcome>
  <enrollment type="Anticipated">540</enrollment>
  <condition>Kidney Failure, Chronic</condition>
  <condition>Arrhythmias, Cardiac</condition>
  <condition>Heart Diseases</condition>
  <condition>Cardiovascular Diseases</condition>
  <condition>Kidney Diseases</condition>
  <condition>Renal Insufficiency, Chronic</condition>
  <condition>Renal Insufficiency</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Holter-monitor</intervention_name>
    <description>7-day holtermonitoring of each patient</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with dialysis-treated end-stage renal disease over the age of 18 and without&#xD;
        pacemaker implantation.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Dialysis-treated end-stage renal disease&#xD;
&#xD;
          -  Age ≥ 18 years&#xD;
&#xD;
          -  Competence to understand the study rationale necessary for written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pre-existing pacemaker implantation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Nicholas Carlson, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rigshospitalet, Denmark</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nicholas Carlson, MD PhD</last_name>
    <phone>+4535455927</phone>
    <email>nicholas.carlson.01@regionh.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ellen Linnea F Ballegaard, MD</last_name>
    <phone>+4535457276</phone>
    <email>ellen.linnea.freese.ballegaard@regionh.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Dept. of Nephrology, Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicholas Carlson, MD PHD</last_name>
      <phone>0045 35455927</phone>
      <email>nicholas.carlson.01@regionh.dk</email>
    </contact>
    <contact_backup>
      <last_name>Ellen Linnea F Ballegaard, MD</last_name>
      <phone>0045 35457276</phone>
      <email>ellen.linnea.freese.ballegaard@regionh.dk</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Herlev Hospital</name>
      <address>
        <city>Herlev</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>North Zealand Hospital</name>
      <address>
        <city>Hillerød</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>May 3, 2021</study_first_submitted>
  <study_first_submitted_qc>May 3, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 7, 2021</study_first_posted>
  <last_update_submitted>November 5, 2021</last_update_submitted>
  <last_update_submitted_qc>November 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Nicholas Carlson</investigator_full_name>
    <investigator_title>MD PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Arrhythmias, Cardiac</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Tabulated study data and protocols will be made available (within limitations of Danish legislation related to GDPR)</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>within 1 year of study completion</ipd_time_frame>
    <ipd_access_criteria>Data access will be available upon approval via Statistics Denmark</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

